Supplementary Table 1 - Main characteristics of studies on oral tofacitinib and ruxolitinib for the treatment of alopecia areata
收藏NIAID Data Ecosystem2026-03-11 收录
官方服务：
资源简介：
Supplementary table for the publication by Yu DA et al. Oral Janus kinase inhibitors for the treatment of alopecia areata: a systematic review and meta-analysis. J Am Acad Dermatol 2019.
创建时间：
2019-08-12
